Hinge Health Acquires Cylinder Health for $105M, Adding GI Care
HNGE has more than doubled off its 52-week low of $30.08.
Summary
Hinge Health is buying Cylinder Health for $105 million in cash, moving into gastrointestinal care. The deal expands its digital health platform beyond musculoskeletal into a new therapeutic area. It follows a strong Q2 where revenue surged 53% to $212.8M, beating consensus by $11.8M. The acquisition is expected to close in Q3 2026, adding a complementary service line that could accelerate cross-selling and revenue growth.
At the time of this announcement, HNGE was trading at $78.74 on NYSE in the Life Sciences sector, with a market capitalization of approximately $6.1B. The 52-week trading range was $30.08 to $91.50. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.